Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
Treatment of Parkinson's disease aims to replace dopaminergic transmission at striatal synapses. In the normal state, nigral neurons fire continuously, exposing striatal dopamine receptors to relatively constant levels of dopamine. In the disease state, periodic dosing and the short half-life o...
Main Authors: | O.K. Sujith, Carol Lane |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-03-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285608101378 |
Similar Items
-
Dopaminergic agonists in Parkinson's disease
by: A. Alonso Cánovas, et al.
Published: (2014-05-01) -
LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01) -
Non-Dopaminergic Systems in Parkinson's Disease
Published: (2020) -
Mechanisms of Dopaminergic Neurodegeneration in Parkinson's Disease
by: Verma, Aditi
Published: (2018) -
Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism
by: J. Vaamonde Gamo, et al.
Published: (2010-01-01)